Tobacco Regulatory Science in Action: In the Researchers' Own Words
Scientific research underpins our regulatory work and grounds our efforts to improve public health and reduce disease and death caused by tobacco use. In addition to carrying out our own research, CTP conducts research to support regulatory activities through unique interagency partnerships with the National Institutes of Health (NIH), as well as the Centers for Disease Control and Prevention (CDC) and FDA's National Center for Toxicological Research.
Meet some of the people who are leading important tobacco regulatory research. In their own words, they share the work they are doing, and not only why it is so important to public health, but also to each of them personally.*
These 10 videos in the series represent a cross section of the work under way around a variety of topics, including perceptions and misperceptions of tobacco products, use of tobacco products and preferences of tobacco users, and the behavioral and physiological effects of using various tobacco products.
*The opinions in these videos reflect the views of individual researchers, and not necessarily the official position of the FDA's Center for Tobacco Products. These videos represent accurate information about the design of these CTP supported studies at the time the interviews were conducted (Spring 2014).
Dr. Higgins and his team at the University of Vermont's Tobacco Center of Regulatory Science study how reducing the nicotine levels in cigarettes may change smoking behavior in vulnerable populations.
Dr. Krishnan-Sarin and her team of researchers at the Yale University Tobacco Center of Regulatory Science study the impact of flavors on tobacco use.
Dr. Blount and his team at the CDC are focused on applying "gold standard" analytical methods to characterizing tobacco products.
Dr. Wewers and the Ohio State University Center of Excellence in Tobacco Regulatory Science program study why youth and adults decide to start using, or continue to use, tobacco products.
Through the University of Pennsylvania Tobacco Center of Regulatory Science, Dr. Lerman and colleagues are conducting studies related to understanding tobacco-related messaging, information, and misinformation received through mass media, social media, user commentary, and cigarette packaging.
Dr. Donny's NIH research project at the University of Pittsburgh will measure how a marked reduction in the nicotine content of cigarettes impacts the use and effects of tobacco in current smokers.
Dr. Ribisl and his research team with the University of North Carolina Tobacco Center of Regulatory Science work to improve messages about the content of cigarette smoke, emerging tobacco products, and the FDA's regulatory authority over tobacco products.
Dr. Abnet's research looks specifically at how tobacco product use affects the mouth and the oral microbiome (the bacteria that commonly exist in the mouth) to better understand the scope of tobacco-related mouth disease.
Dr. Sterling studies young adults, particularly minority populations, to understand their unique perceptions of certain tobacco products.
Dr. Hyland, colleagues, and Westat are following adults and youth over time to monitor and assess behaviors, attitudes, biomarkers, and health outcomes associated with tobacco use in the U.S. via the FDA & NIH study called the Population Assessment of Tobacco and Health (PATH).
"I think that the work that's being done here, not only the PATH Study, but across the FDA-funded projects, will be looked upon in the future as a groundbreaking, necessary endeavor in order to save lives."
Andrew Hyland, Ph.D., Roswell Park Cancer Institute
What tobacco-related research is supported by the FDA?
The videos explore a broad range of tobacco research topics, including:
- Diversity of tobacco products
- Toxicity and carcinogenicity
- Adverse health consequences
- Communications about tobacco products
- Tobacco product marketing
- Effects of economics and policies
View CTP research areas and priorities.
These studies will provide important new evidence that informs regulatory decision making to positively impact the health of people.